Home Finance Guggenheim raises Rapport Therapeutics price target to $70 on trial data
Finance

Guggenheim raises Rapport Therapeutics price target to $70 on trial data

Share
Guggenheim raises Rapport Therapeutics price target to  on trial data
Share


Guggenheim raises Rapport Therapeutics price target to $70 on trial data

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *